Caregen , Ltd. EBIT

As of the most recent data (June 2026), 214370.KQ shows a EBIT of $22B. That compares with $42B in the prior-year period — down 47.2% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 214370.KQ's EBIT is now $22B (was $42B) — a 47.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Caregen , Ltd. is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. Caregen , Ltd. is at $22B, which is lower that average. That is roughly 99.1% below the sector mean. Use the comparison chart on this page to see how 214370.KQ stacks up against individual peers as well.

Tracking 214370.KQ's ebit over time shows whether Caregen , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $22B That compares with $42B in the prior-year period — down 47.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Caregen , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $22B) with ownership activity and broader fundamentals.